Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @big4bioBOS
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @big4bioBOS
-
How did Boston’s
#lifesciences industry fare in 2019? Read the#Big4Bio 2019 Year-in-Review for Boston: https://big4bio.com/spotlights/spotlight-big4bioboston-2019-year-in-review/ …pic.twitter.com/luJO4wQ6ON
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Boston proslijedio/la je Tweet
1,300+ scientists and clinicians analyzed 2,600+ whole genomes of 38 different tumor types over the last six years, completing the most comprehensive study of whole
#cancer genomes to date and significantly improving our understanding of cancer.https://cards.twitter.com/cards/18ce53unycc/8xrhh …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Boston proslijedio/la je Tweet
On BioGenesis podcast, Kwadwo Owusu-Boaitey of the Reddien lab recalls how tumor board meetings at Greenebaum Cancer Center
@UMGCCC helped shape his decision to pursue an MD-PhD with@mit_hst and become a physician-scientist:#IAmAndIWill
#WorldCancerDay
@ScienceMIT@MITBiologypic.twitter.com/wRKw6E53iePrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Boston proslijedio/la je Tweet
Magenta Therapeutics is pleased to announce the expansion of our senior leadership team: Kristen Stants as Chief People Officer and Li Malmberg, Ph.D., as SVP, Head of Manufacturing. More here: https://investor.magentatx.com/news-releases/news-release-details/magenta-therapeutics-expands-leadership-team-appoints-kristen …pic.twitter.com/KIph69LoE6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LifeSciences Innovators: Pitch your ideas in the 2020@UMassM2D2 $200K Challenge! ENTRIES CLOSE FEB 16: https://buff.ly/2VsmVWu#200KChallenge#GoForIt#medicaldevice#medtech#biotech#startups#coronavirus#HealthSecurity#InfectiousDisease@BARDApic.twitter.com/WjkvViBp21
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Today’s approval of Ayvakit brings forward a new standard of care for patients with PDGFRA exon 18 mutant GIST, a genomically defined population that previously had very limited treatment options."
$ALNY$BPMChttps://www.biospace.com/article/fda-action-alert-alnylam-and-blueprint-medicines …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LifeSciences Innovators: Pitch your ideas in the 2020@UMassM2D2 $200K Challenge! ENTRIES CLOSE FEB 16: https://buff.ly/2VsmVWu#200KChallenge#GoForIt#medicaldevice#medtech#biotech#startups#coronavirus#HealthSecurity#InfectiousDisease@BARDApic.twitter.com/jvL7mCRwZw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Boston proslijedio/la je Tweet
Feb 27 Event
@BlueprintMeds. Join a lively discussion around planning for a transition from dev stage to commercial company. Find out what to do before, during and after receiving that sought-after approval.#biotech#WIBBoston#fdaapproval#medicineshttps://www.womeninbio.org/events/EventDetails.aspx?id=1333744&group= …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FREE VENTURE FUNDING HAPPY HOUR
TONIGHT @UMassM2D2#LifeSciences#startups: Venture Funding MUST be part of your success plan! Learn from noted investors. Network. PLUS join the#200KChallenge info session. See you after work! RSVP: https://buff.ly/39xCjIn pic.twitter.com/eTHcGOGxrQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Boston proslijedio/la je Tweet
More disputes on AI-style drug discovery, and hopes that the field can eventually get past this phase:https://blogs.sciencemag.org/pipeline/archives/2020/02/04/arguing-on-ai-drug-discovery …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LifeSciences Innovators: Pitch your ideas in the 2020@UMassM2D2 $200K Challenge! ENTRIES CLOSE FEB 16: https://buff.ly/2VsmVWu#200KChallenge#GoForIt#medicaldevice#medtech#biotech#startups#coronavirus#HealthSecurity#InfectiousDisease@BARDApic.twitter.com/EfLLPVg2mZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Big4Bio:Boston proslijedio/la je Tweet
"The truth is, a gene mutation alone isn’t enough to explain whether someone will develop cancer. There are millions of other variants—DNA differences..." How so-called "junk DNA" affects cancer risk, J Quackenbush
@HarvardChanSPH https://www.hsph.harvard.edu/news/features/how-so-called-junk-dna-affects-cancer-risk/ … ht@LguzzardiM#genomicsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FREE VENTURE FUNDING HAPPY HOUR
TOMORROW @UMassM2D2#LifeSciences#startups: Venture Funding MUST be part of your success plan! Learn from noted investors. Network. PLUS join the#200KChallenge info session. See you after work! RSVP: https://buff.ly/39xCjIn pic.twitter.com/HERB6UoJGf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sandra Horning, M.D. To Join
@moderna_tx Board of Directors "Former@genentech /Roche Chief Medical Officer and Head of Global Product Development will bring extensive global biopharma expertise to support Moderna’s late-stage development efforts" https://www.businesswire.com/news/home/20200203005380/en/Sandra-Horning-M.D.-Join-Moderna%E2%80%99s-Board-Directors …$MRNAHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Boston proslijedio/la je Tweet
Now is your chance to save $400 off your PEGS Summit registration! Discounted rates expire this Friday, February 7. View registration and pricing options: https://www.PEGSummit.com pic.twitter.com/uri2ajpfUJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Big4Bio:Boston proslijedio/la je Tweet
"Call Me, Maybe" - Synlogic CEO
@aoifemlbrennan reflects on pros/cons of the quarterly earnings call for young biotech companies as a new From The Trenches post. https://lifescivc.com/2020/02/call-me-maybe/ …pic.twitter.com/dSo5adOaaO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
These are the Massachusetts-based
#biotech and#pharma companies that raised a total of $96.7 million this week:https://www.bizjournals.com/boston/news/2020/01/31/form-d-friday-local-biotech-companies-raise-almost.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LifeSciences Innovators: Pitch your ideas in the 2020@UMassM2D2 $200K Challenge! ENTRIES CLOSE FEB 16: https://buff.ly/2VsmVWu#200KChallenge#GoForIt#medicaldevice#medtech#biotech#startups#coronavirus#HealthSecurity#InfectiousDisease@BARDApic.twitter.com/kuKzXsI1JL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The first-ever Year-in-Review report for Boston was published yesterday. Have you taken a look yet? https://big4bio.com/spotlights/spotlight-big4bioboston-2019-year-in-review/ …pic.twitter.com/nrIVSQYS6i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.